Ceska Televize: MLS® enters the fray for treating COVID-19 pneumonia

21 January 2021 - Therapies -

After viewing the successful results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using MLS® Laser Therapy for a clinical trial to treat interstitial pneumonia caused by COVID-19, this was also adopted by the doctors in the Covid Unit of the Kolin Hospital, in Bohemia.

This was announced by Ceska Televize, the TV channel in the Czech Republic, which interviewed the chief physician of the facility:

“Following our direct experience, we confirm the value of MLS® in the treatment of interstitial pneumonia caused by the virus. Its action consists in reducing the progress of the tissue inflammation, with consequences also on pulmonary fibrotization”.

You might also be interested in ...

See all articles

M6 laser & pain management
news - 21/01/2021
“Following our direct experience, we confirm the conclusions reached in America in relation to the value of MLS® for treating interstitial pneumonia caused by the virus. Its action consists in...
COVID19 case report - laser beam positioning
blog - 02/10/2020
A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.
First Use of PBMT in COVID-19
Research
S.A. Sigman, S. Mokmeli, M. Monici, M. A. Vetrici American Journal of Case Reports, 21:e926779, 2020  This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia....
Press - 28/04/2025
From photovoltaic system to green vehicle fleet, from careful waste management to recycling plastic bottles: the Vicenza-based company focuses on concrete actions to promote the spread of an...
Press - 22/04/2025
The brand-new rehabilitation centre in Námestovo, in northern Slovakia, is already considered to be one of the most modern facilities in the country.
Dolore alla spalla emiplegica - trattamento laser MLS
Blog - 17/04/2025
One of the most frequent complications after a stroke is hemiplegic shoulder pain (HSP), a problem that affects up to 70% of patients and often hinders the rehabilitation process.